Seaside Therapeutics is creating a new Autism drug treatment

Seaside Therapeutics Reports Positive Data from Phase 2 Study of STX209 in Autism Spectrum Disorders.  Study to Advance.

And reports advances in the treatment of Fragile X Syndrome.

They have a pipeline summary of the drugs they are investigating for treatment of Autism and Fragile X.

May 1, 2011 · PTENLife · No Comments
Tags: , ,  · Posted in: Autism, PTEN Life, Treatment